Gilead Raday

Gilead Raday is the Chief Operating Officer & Head of R&D at RedHill Biopharma. Gilead previously served as interim CEO of Sepal Pharma, and as a director at TK Signal and Morria Biopharmaceuticals. He is a graduate of the University of Cambridge (M.Sc. in Bioscience Enterprise) and the Hebrew University of Jerusalem (M.Sc. Neurobiology, BSc Mathematics and Biology).

Posts by Gilead Raday